Reduces hyperlipidemia‐induced cardiac damages by Suppressing lipid deposition (LOX‐1 and CD36) and cardiac fibrosis (MMP2, MMP9, collagen I, collagen III, and TGF‐β). Here, OLR1 is linked to hyperlipidemia.